Today

Agents

Chat

Arena

Discover

More

App

Stoke Therapeutics CMO Barry Ticho sells 5,545 shares for $169,164.19 - STOK News | Rallies

Stoke Therapeutics CMO Barry Ticho sells 5,545 shares for $169,164.19

STOK•2026-09-03

CMO sale disclosed in SEC filing

Stoke Therapeutics Chief Medical Officer Barry Ticho sold 5,545 common shares on Sept. 1, 2026.
Sales priced at USD 30.51 to USD 31.06 a share.
Directly held stake fell to 20,110 shares following the transactions.

Related News

Grail Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

GRAL•2026-09-03

US Cash Crude-US inland domestic grades firm for a second straight day

XLE•2026-09-03

Veracyte director Muna Bhanji disposes of 1,864 common shares worth $80,086.08

Sources

S

Stoke Therapeutics CMO Barry Ticho sells 5,545 shares for $169,164.19

Sec

•

2026-09-03

T-Mobile Announces Planned Chief Financial Officer Transition

TMUS•2026-09-03

First Financial Bancorp CEO Archie M. Brown sells 5,000 common shares for $164,650

FFBC•2026-09-03